Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
202.5 GBX | -14.92% | -19.00% | -33.61% |
05-20 | Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study | MT |
05-20 | Faron Pharma celebrates positive read-out in ongoing MDS trial | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.61% | 218M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.70% | 21.97B | |
-4.45% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals Oy : Earnings Flash (FARN.L) FARON PHARMACEUTICALS Reports H1 Revenue EUR0